Antidiabetic treatment for NASH?

Hepatology

Volumn 33, Issue 5, 2001, Pages 1338-1339

  Maher, Jacquelyn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYL COENZYME A CARBOXYLASE; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; FATTY ACID SYNTHASE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN; TROGLITAZONE; TUMOR NECROSIS FACTOR;

DIET SUPPLEMENTATION; DRUG MECHANISM; DRUG TARGETING; FATTY LIVER; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; RISK ASSESSMENT; RISK FACTOR; WEIGHT REDUCTION;

EID: 0035038280     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.0331338     Document Type: Article

References (11)

1. The natural history of nonalcoholic fatty liver: A followup study
2. Non-alcoholic steatohepatitis: Association with obesity and insulin resistance, and influence of weight loss
3. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
4. Dual effect of metformin in cultured rat hepatocytes: Potentiation of insulin action and prevention of insulin-induced resistance
5. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
6. Antihyperglycemic actions of guanidenoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL-6j ob/ob mice and increases glucose disappearance in Rhesus monkeys
7. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes
8. Protection from obesity-induced insulin resistance in mice lacking TNF-α function
9. TNF-α is not the cause of fatty liver disease in obese diabetic mice
10. Upregulation of uncoupling protein 2 mRNA in genetic obesity: Lack of an essential role for leptin, hyperphagia, increased tissue lipid content, and TNF-α
11. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis